What is Bio Protocol (BIO)?

Bio Protocol (BIO) is a management and liquidity provider protocol designed to advance decentralized science (DeSci).

BIO's mission is to accelerate the biotechnology industry by empowering patients, scientists and global biotech experts to fund, develop and own projects and intellectual property (IP) in the form of tokens.

The Bio Protocol team includes experts who were involved in the establishment of Molecule, a platform for tokenizing medical projects, and VitaDAO, a decentralized community focused on the science of longevity.

What problem does Bio Protocol solve?

Traditional biotech research often faces difficulties such as high costs, slow funding processes, and difficulty for smaller organizations to obtain intellectual property. BIO uses blockchain to break down these barriers.

Bioconomy

BIO's vision is to build a community-led ecosystem, the "Bioconomy," where innovation is not hindered by outdated systems.

By decentralizing the biotechnology funding and development process, BIO provides opportunities for new ideas to come to fruition.

Rather than relying on a few large institutions, BIO empowers a global network to collectively contribute resources, vote on promising projects, and share ownership of scientific results.

BIO Protocol

At the core of the project is the BIO Protocol, a protocol that establishes a framework for the development of decentralized biotechnology.

The main components include:

  • BioDaos: A decentralized autonomous organization focused on a specific area of ​​biotechnology, such as gene editing, cancer research, or vaccine development. BioDaos members contribute resources, make decisions together, and share results.

  • Curation Mechanism: As the number of projects increases, it is a challenge to prioritize projects. BIO uses a community voting mechanism to identify promising projects and ensure that resources are used effectively.

  • Bio/Acc Rewards: This program incentivizes community participation through token rewards, based on expertise, financial or creative contributions.

  • IP Tokens: One of the highlights of BIO is the tokenization of intellectual property. Instead of locking scientific breakthroughs in private libraries, IP is converted into digital tokens. This enables more people to invest in and benefit from scientific progress.

Ecosystems and governance

BIO connects stakeholders in the biotechnology industry, from researchers to investors to patients, giving everyone a voice.

Governance power is decentralized, allowing token holders to participate in the direction of the project. This ensures transparency and is in the best interests of the community.

BIO Token

BIO tokens serve as a utility and governance tool in the BIO ecosystem. Token holders can:

  • Support for specific BioDaos.

  • Vote on whether to create or distribute new tokens.

  • Participate in early-stage funding rounds and receive financial rewards for providing health data or participating in clinical trials.

BIO Token Details

  • Name:Bio Protocol

  • Symbol: BIO

  • Token Type: Utility

  • Blockchain: Ethereum

  • Contract: 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA

  • Total Supply: 3,320,000,000 BIO

Token Allocation

  • Ecosystem development: 25%

  • Core Contributors: 21.2%

  • Community auction: 20%

  • Investors: 13.6%

  • Community airdrop: 6%

  • Molecule Ecosystem Fund: 5%

  • Molecule:5%

  • Consultant: 4.2%

BIO Launch Pad

BIO's LaunchPad is a platform that supports the launch and financing of emerging biotech projects. It provides tools and resources to help project teams connect with supportive communities and potential partners.

BioDaos Incubator

BIO also provides an incubator program to support the development of new BioDaos, providing guidance, resources and a clear working framework to ensure innovation and sustainable development in the ecosystem.

in conclusion

BIO brings a more open and collaborative approach to biotechnology research. Unlike traditional structure constraints, BIO creates opportunities for diverse communities to work together to advance progress.

By tokenizing intellectual property and decentralizing governance, BIO unlocks innovation opportunities that may have been overlooked in the past.

For researchers, it's a chance to get faster, more equitable funding. For patients and advocates, it's a way to directly support major breakthroughs.